Myovant Competitors

MYOV -  USA Stock  

USD 22.27  0.00  0.00%

Myovant Sciences competes with Equillium, Diamedica Therapeutics, Denali Therapeutics, Dicerna Pharmaceutic, and Design Therapeutics; as well as few others. The company conducts business under Healthcare sector and is part of Biotechnology industry. Analyzing Myovant Sciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Myovant Sciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Myovant Sciences competition on your existing holdings. Additionally, see Myovant Sciences Correlation with its peers.

Search Competition 

 
Refresh
Return on Average Equity is likely to climb to 1.09 in 2021, whereas Return on Average Assets are likely to drop (0.63)  in 2021. Myovant Sciences Total Assets are fairly stable at the moment as compared to the past year. Myovant Sciences reported Total Assets of 725.03 Million in 2020. Current Assets is likely to climb to about 760.3 M in 2021, whereas Return on Average Assets are likely to drop (0.63)  in 2021.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Myovant Sciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Myovant Sciences in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
19.2822.2725.26
Details
Intrinsic
Valuation
LowReal ValueHigh
20.0426.8729.86
Details
Naive
Forecast
LowNext ValueHigh
17.0720.0623.05
Details
4 Analysts
Consensus
LowTarget PriceHigh
24.0034.7555.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Myovant Sciences. Your research has to be compared to or analyzed against Myovant Sciences' peers to derive any actionable benefits. When done correctly, Myovant Sciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Myovant Sciences.

Myovant Sciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Myovant Sciences and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Myovant and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Myovant Sciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Myovant Sciences Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Myovant Sciences stock performing well and Myovant Sciences company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Myovant Sciences' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
EQ
 3.21  0.30  0.07 (0.51)  3.53  0.05 (3.83)  8.49 (5.99)  30.83 
DMAC
 4.31 (0.77)  0.00  2.34  0.00 (0.13)  0.00  6.70 (8.85)  35.72 
DNLI
 2.27 (0.46)  0.00 (5.29)  0.00 (0.15)  0.00  5.09 (4.94)  18.67 
DRNA
 2.55 (0.81)  0.00  1.27  0.00 (0.19)  0.00  4.11 (5.30)  32.25 
DSGN
 2.82 (0.32)  0.00  0.40  0.00 (0.1)  0.00  6.19 (7.33)  25.12 
DTIL
 2.79  0.29  0.07  0.56  3.43  0.07 (3.10)  6.58 (5.15)  24.86 
DVAX
 3.86  1.22  0.26 (25.36)  3.91  0.21 (4.69)  8.07 (6.89)  29.34 
DYAI
 4.57  0.85  0.16  1.07  4.48  0.11 (5.87)  10.48 (8.78)  61.31 
EDSA
 4.40  1.23  0.22  0.77  4.85  0.09 (6.19)  5.34 (4.54)  132.59 

Cross Equities Net Income Analysis

Select Fundamental

201020112012201320142015201620172018201920202021
EQ
(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(25.6 M)(29.8 M)(32.2 M)
DMAC
(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(4.3 M)(5.7 M)(10.6 M)(12.3 M)(12.6 M)
DNLI
(16.8 M)(16.8 M)(16.8 M)(16.8 M)(16.8 M)(16.8 M)(86.7 M)(88.2 M)(36.2 M)(197.6 M)71.1 M76.8 M
DRNA
(8.6 M)(8.6 M)(10.1 M)(18.5 M)(47.9 M)(62.8 M)(59.5 M)(60.2 M)(88.9 M)(120.5 M)(112.7 M)(115.7 M)
DSGN
(2 M)(2 M)(2 M)(2 M)(2 M)(2 M)(2 M)(2 M)(2 M)(2 M)(8.3 M)(8.5 M)
DTIL
(21.1 M)(21.1 M)(21.1 M)(21.1 M)(21.1 M)(21.1 M)(21.1 M)(21.1 M)(46 M)(92.9 M)(109 M)(111.9 M)
DVAX
(57.3 M)(48.6 M)(69.9 M)(66.7 M)(90.7 M)(106.8 M)(112.4 M)(95.2 M)(158.9 M)(152.6 M)(75.2 M)(81.2 M)
DYAI
(3.6 M)(3.6 M)(3.6 M)(3.6 M)(3.6 M)(3.6 M)(3.6 M)(2.1 M)(5.7 M)(8.3 M)(9.3 M)(9.6 M)
EDSA
(2.8 M)(2.8 M)(2.8 M)(2.8 M)(2.8 M)(5 M)(5 M)(6.4 M)(1.9 M)(6.4 M)(1.9 M)(2 M)

Myovant Sciences and related stocks such as Equillium, Diamedica Therapeutics, Denali Therapeutics, Dicerna Pharmaceutic, Design Therapeutics, Precision Biosciences, Dynavax Technologies, Dyadic International, and Edesa Biotech Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Myovant Sciences financial statement analysis. It represents the amount of money remaining after all of Myovant Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Myovant Sciences Competitive Analysis

The better you understand Myovant Sciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Myovant Sciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Myovant Sciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MYOV
EQ
DMAC
DNLI
DRNA
DSGN
DTIL
DVAX
DYAI
EDSA
 0.00 
 22.27 
Myovant
 3.54 
 6.73 
Equillium
 1.78 
 3.87 
Diamedica
 2.59 
 51.98 
Denali
 2.71 
 20.10 
Dicerna
 4.27 
 15.02 
Design
 1.43 
 12.76 
Precision
 18.92 
 18.79 
Dynavax
 2.09 
 5.62 
Dyadic
 1.76 
 8.24 
Edesa
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Current Liabilities
Price to Earnings To Growth
Total Asset
Short Ratio
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Rate Of Daily Change
Day Median Price
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Myovant Sciences Competition Performance Charts

Complement your Myovant Sciences position

In addition to having Myovant Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electrical Equipment Thematic Idea Now

Electrical Equipment
Electrical Equipment Theme
Fama and French focuses on testing asset pricing under different economic assumptions. Electrical Equipment theme has 31 constituents.
View All  Next Launch Electrical Equipment
Additionally, see Myovant Sciences Correlation with its peers. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Myovant Stock analysis

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.